Tsipi Meshel
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
PD-L1 and PD-L2 regulate in cell-autonomous and N-glycosylation-dependent manners the pro-tumorigenic characteristics and functions of human cancer-associated fibroblasts.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 12, 2026
M196R-TNFR2 and membrane TNFα down-regulate soluble TNFα-induced pro-metastatic functions in triple-negative breast cancer cells.
Journal: Cancer cell international
Published: September 10, 2025
N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1.
Journal: Molecular cancer
Published: January 11, 2025
A heterodimer of hemoglobin identifies theranostic targets on brain-metastasizing melanoma cells.
Journal: International journal of cancer
Published: October 28, 2024
The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1.
Journal: Cells
Published: August 15, 2023
Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression.
Journal: Cancers
Published: August 08, 2023
The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway.
Journal: Cells
Published: March 28, 2023
A Tumor Microenvironment-Driven Network Regulated by STAT3 and p65 Negatively Controls the Enrichment of Cancer Stem Cells in Human HR+/HER2- Breast Cancer.
Journal: Cancers
Published: March 20, 2023
LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance.
Journal: ImmunoHorizons
Published: March 09, 2022
Last Updated: 09/26/2026